This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (61)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Calvin C. Linnemann, Jr, MD; M. Roy First, MD; Gerald Schiffman, PhD

Arch Intern Med. 1986;146(8):1554-1556.

Abstract
• Two years after pneumococcal vaccine was given to patients on a university renal transplant and hemodialysis service, vaccine failures began to occur. Serologic studies showed a threefold decrease in antibody levels during this period, from 913 ng of antibody nitrogen per milliliter to 315 ng/mL. The decrease was greater in patients undergoing hemodialysis than in renal transplant recipients (879 to 215 ng/mL vs 932 to 385 ng/mL). The lowest antibody levels were to types 4,6A, and 19F. Patients were revaccinated, without serious reactions, and pneumococcal infections decreased as they had after the original vaccination program. After revaccination, there was a twofold increase in antibody levels (315 to 602 ng/mL), but the levels did not reach those seen after primary vaccination. The increase was greater in hemodialysis than in renal transplant recipients (215 to 757 ng/mL vs 385 to 536 ng/mL). This experience indicates that pneumococcal vaccines may be effective in patients undergoing hemodialysis and in asplenic renal transplant recipients, but these groups will require revaccination sooner than normal subjects to maintain immunity.

(Arch Intern Med 1986;146:1554-1556)

Author Affiliations
From the Department of Internal Medicine, University of Cincinnati College of Medicine (Drs Linnemann and First), and the Department of Microbiology and Immunology, State University of New York, Brooklyn (Dr Schiffman).

Footnotes
Accepted for publication Dec 4, 1985.

Reprint requests to Division of Infectious Diseases, University of Cincinnati College of Medicine, 231 Bethesda Ave, ML-560, Cincinnati, OH 45267-0560 (Dr Linnemann).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols
Duchini et al.
Clin. Microbiol. Rev. 2003;16:357-364.
ABSTRACT | FULL TEXT  

Fatal necrotizing fasciitis due to Streptococcus pneumoniae after renal transplantation
Imhof et al.
Nephrol Dial Transplant 2003;18:195-197.
FULL TEXT  

Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
KASISKE et al.
J. Am. Soc. Nephrol. 2000;11 :S1-S86.
ABSTRACT | FULL TEXT  

Safety of Revaccination With Pneumococcal Polysaccharide Vaccine
Jackson et al.
JAMA 1999;281:243-248.
ABSTRACT | FULL TEXT  

Pneumococcal vaccine for HIV patients
McDonald et al.
BMJ 1995;311:387b-388.
FULL TEXT  

Efficacy of Pneumococcal Vaccination in Adults: A Meta-analysis of Randomized Controlled Trials
Fine et al.
Arch Intern Med 1994;154:2666-2677.
ABSTRACT  

Immunogenicity of Pneumococcal Revaccination in Patients With Chronic Disease
Davidson et al.
Arch Intern Med 1994;154:2209-2214.
ABSTRACT  

Pneumococcal Polysaccharide Vaccine Efficacy: An Evaluation of Current Recommendations
Butler et al.
JAMA 1993;270:1826-1831.
ABSTRACT  

New Issues in Geriatric Care
SOLOMON et al.
ANN INTERN MED 1988;108:718-732.
ABSTRACT